Polycystic kidney disease pathway (Homo sapiens)
From WikiPathways
Description
A putative PKD pathway proposed in Torres 2009 (Figure 2), showing up- or downregulated genes.
Quality Tags
Ontology Terms
Cell Type : dopaminergic neuron
Bibliography
- Torres VE, Harris PC; ''Autosomal dominant polycystic kidney disease: the last 3 years.''; Kidney Int, 2009 PubMed Europe PMC Scholia
- ''Growth hormone synthesis, secretion and action''; https://www.genome.jp/pathway/hsa04935,
History
View all... |
External references
DataNodes
View all... |
Name ![]() | Type ![]() | Database reference ![]() | Comment ![]() |
---|---|---|---|
GeneProduct | |||
AMPK | GeneProduct | ||
ATP | Metabolite | ||
Ac-VI | |||
CDK inhibitors | Metabolite | ||
Ca2+ | Metabolite | 271 (PubChem-compound) ![]() | |
Decreased in PKD | |||
Dvl | |||
ERK | GeneProduct | ||
GSK3beta | GeneProduct | ||
Increased in PKD | |||
MEK | GeneProduct | ||
MEK inh | Metabolite | ||
Metformin | Metabolite | ||
Nucleus | |||
PDE | GeneProduct | ||
PKA | |||
Protein Synthesis | Pathway | ||
RSK | GeneProduct | ||
Rheb | GeneProduct | ||
TSC1 | GeneProduct | ||
TSC2 | GeneProduct | ||
cAMP | Metabolite | ||
cyclinD | GeneProduct | ||
mTOR | GeneProduct | ||
mTOR inhibitors | Metabolite |
Annotated Interactions
No annotated interactions